ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2538

Ultrasound-Guided Core Needle Biopsy of the Major Salivary Glands Is a Safe and Useful Diagnostic Tool in the Evaluation of Suspected or Established Sjögren’s Syndrome

Anand Narayan1, Thomas Grader-Beck2, Julius Birnbaum3, Jean Kim4, Qing Kay Li5, Deborah Belchis5, Joel Fradin1 and Alan N. Baer6, 1Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, 2Medicine Div of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 4Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 5Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: biopsies, MALT lymphoma, salivary gland and ultrasonography, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjogren's Syndrome: Clinical Science

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Ultrasound-guided core needle biopsy (CNB) has greater inherent risks than fine-needle aspiration for the diagnosis of major salivary gland neoplasms, but provides tissue for histologic analysis. We sought to evaluate the safety and utility of CNB in the evaluation of salivary gland abnormalities in patients with suspected or established Sjögren’s syndrome (SS).

Methods:

We identified 19 patients who underwent ultrasound-guided CNB of either the parotid or submandibular gland as part of a diagnostic evaluation in our SS Center between 7/2009-5/2014. CNBs of the parotids were obtained using a posterior-inferior approach from the tail of the superficial lobe to avoid injury to the facial nerve. Patients were contacted one day after the procedure to assess for complications. The patient charts were reviewed retrospectively, using a protocol approved by the institutional review board.

Results:

The 5 men and 14 women had a median age of 55 years (range, 19-74). Seven patients had an established SS diagnosis and underwent the procedure to exclude lymphoma as the cause for symmetric or asymmetric salivary gland enlargement. The remaining 12 with suspected SS underwent the procedure because of bilateral salivary gland enlargement and/or induration (n=11) or an elevated serum IgG4 level (n=1), but only one was diagnosed with SS. The 19 procedures involved sampling of parotid (n=14) or submandibular (n=5) gland parenchyma and constituted CNB alone (n=9) and CNB with FNA (n=10); flow cytometry was performed on 7/10 FNA samples. None of the patients reported complications one day  post-procedure or during longitudinal follow-up [median (range) duration=172 days (1-924)]. Among the established SS patients, 3/6 had a clonal B-cell population on FNA flow cytometry, but lymphoma was only diagnosed in 1 based on CNB histology. The remaining 2 patients with abnormal FNA flow cytometry had CNB histology of benign lymphoepithelial sialadenitis and did not develop signs of lymphoma during follow-up of 2.3-2.5 years. One patient with established SS underwent CNB alone and the histology showed no lymphoid aggregates. Among the 12 patients with suspected SS, final pathologic diagnoses from CNB included: eosinophilic sialadenitis (n=2), normal parotid gland tissue with/without fatty infiltration (n=8), chronic sialadenitis not related to SS (n=1), and extensive fibrosis (n=1). The utility of CNB as a diagnostic tool for salivary gland disease was supported by its identification of: 1) pathologic abnormalities (lymphoid infiltrates or >50% fibrosis) in 10/10 patients with abnormal salivary gland ultrasound echotexture and 2) lymphoid infiltrates in 5/8 patients with established SS. Three patients with enlarged parotid glands but normal ultrasound echotexture had a CNB showing fatty infiltration with normal acinar tissue.

Conclusion:

Ultrasound-guided CNB of the major salivary glands can be done safely and provides useful diagnostic information about salivary gland abnormalities in the evaluation and management of SS. The evaluation of possible lymphoma should include both CNB and FNA with flow cytometric analysis of the sample since the finding of a clonal B-cell population is not sufficient to make a diagnosis of lymphoma.


Disclosure:

A. Narayan,
None;

T. Grader-Beck,
None;

J. Birnbaum,
None;

J. Kim,
None;

Q. K. Li,
None;

D. Belchis,
None;

J. Fradin,
None;

A. N. Baer,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-guided-core-needle-biopsy-of-the-major-salivary-glands-is-a-safe-and-useful-diagnostic-tool-in-the-evaluation-of-suspected-or-established-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology